These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 32277785

  • 1. TGF-β secreted by human umbilical cord blood-derived mesenchymal stem cells ameliorates atopic dermatitis by inhibiting secretion of TNF-α and IgE.
    Park HH, Lee S, Yu Y, Yoo SM, Baek SY, Jung N, Seo KW, Kang KS.
    Stem Cells; 2020 Jul; 38(7):904-916. PubMed ID: 32277785
    [Abstract] [Full Text] [Related]

  • 2. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation.
    Kim HS, Yun JW, Shin TH, Lee SH, Lee BC, Yu KR, Seo Y, Lee S, Kang TW, Choi SW, Seo KW, Kang KS.
    Stem Cells; 2015 Apr; 33(4):1254-66. PubMed ID: 25522163
    [Abstract] [Full Text] [Related]

  • 3. Immunomodulatory Effect of Epidermal Growth Factor Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells on Atopic Dermatitis.
    Jung N, Kong T, Yu Y, Park H, Lee E, Yoo S, Baek S, Lee S, Kang KS.
    Int J Stem Cells; 2022 Aug 30; 15(3):311-323. PubMed ID: 35220283
    [Abstract] [Full Text] [Related]

  • 4. Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies.
    Kim HS, Lee JH, Roh KH, Jun HJ, Kang KS, Kim TY.
    Stem Cells; 2017 Jan 30; 35(1):248-255. PubMed ID: 27256706
    [Abstract] [Full Text] [Related]

  • 5. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS, Shin TH, Lee BC, Yu KR, Seo Y, Lee S, Seo MS, Hong IS, Choi SW, Seo KW, Núñez G, Park JH, Kang KS.
    Gastroenterology; 2013 Dec 30; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [Abstract] [Full Text] [Related]

  • 6. Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling.
    Shin N, Jung N, Lee SE, Kong D, Kim NG, Kook MG, Park H, Choi SW, Lee S, Kang KS.
    Stem Cell Res Ther; 2021 Aug 28; 12(1):482. PubMed ID: 34454603
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo monitoring of dynamic interaction between neutrophil and human umbilical cord blood-derived mesenchymal stem cell in mouse liver during sepsis.
    Ahn SY, Maeng YS, Kim YR, Choe YH, Hwang HS, Hyun YM.
    Stem Cell Res Ther; 2020 Feb 03; 11(1):44. PubMed ID: 32014040
    [Abstract] [Full Text] [Related]

  • 11. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y, Yoo SM, Park HH, Baek SY, Kim YJ, Lee S, Kim YL, Seo KW, Kang KS.
    J Tissue Eng Regen Med; 2019 Oct 03; 13(10):1792-1804. PubMed ID: 31293088
    [Abstract] [Full Text] [Related]

  • 12. Human umbilical cord blood mesenchymal stem cell transplantation suppresses inflammatory responses and neuronal apoptosis during early stage of focal cerebral ischemia in rabbits.
    Zhu Y, Guan YM, Huang HL, Wang QS.
    Acta Pharmacol Sin; 2014 May 03; 35(5):585-91. PubMed ID: 24727940
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
    Kim DH, Lee D, Lim H, Choi SJ, Oh W, Yang YS, Chang JH, Jeon HB.
    Biochem Biophys Res Commun; 2018 Oct 12; 504(4):933-940. PubMed ID: 30224067
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis.
    Yu Y, Yoon KA, Kang TW, Jeon HJ, Sim YB, Choe SH, Baek SY, Lee S, Seo KW, Kang KS.
    J Tissue Eng Regen Med; 2019 Jul 12; 13(7):1134-1142. PubMed ID: 30959558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. VEGF165 gene-modified human umbilical cord blood mesenchymal stem cells protect against acute liver failure in rats.
    Chen H, Tang S, Liao J, Liu M, Lin Y.
    J Gene Med; 2021 Oct 12; 23(10):e3369. PubMed ID: 34057770
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
    Han KH, Kim AK, Kim MH, Kim DH, Go HN, Kang D, Chang JW, Choi SW, Kang KS, Kim DI.
    Tissue Cell; 2017 Dec 12; 49(6):680-690. PubMed ID: 28958480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.